ICON Cash on Hand 2010-2023 | ICLR
- ICON cash on hand for the quarter ending December 31, 2023 was $0.380B, a 30.84% increase year-over-year.
- ICON cash on hand for 2023 was $0.38B, a 30.84% increase from 2022.
- ICON cash on hand for 2022 was $0.29B, a 61.47% decline from 2021.
- ICON cash on hand for 2021 was $0.754B, a 10.46% decline from 2020.
ICON Annual Cash on Hand (Millions of US $) |
|
---|---|
2023 | $380 |
2022 | $290 |
2021 | $754 |
2020 | $842 |
2019 | $570 |
2018 | $456 |
2017 | $360 |
2016 | $261 |
2015 | $190 |
2014 | $216 |
2013 | $321 |
2012 | $190 |
2011 | $174 |
2010 | $256 |
2009 | $194 |
ICON Quarterly Cash on Hand (Millions of US $) |
|
---|---|
2023-12-31 | $380 |
2023-09-30 | $315 |
2023-06-30 | $272 |
2023-03-31 | $282 |
2022-12-31 | $290 |
2022-09-30 | $611 |
2022-06-30 | $617 |
2022-03-31 | $561 |
2021-12-31 | $754 |
2021-09-30 | $1,010 |
2021-06-30 | $1,057 |
2021-03-31 | $944 |
2020-12-31 | $842 |
2020-09-30 | $710 |
2020-06-30 | $594 |
2020-03-31 | $484 |
2019-12-31 | $570 |
2019-09-30 | $471 |
2019-06-30 | $431 |
2019-03-31 | $478 |
2018-12-31 | $456 |
2018-09-30 | $491 |
2018-06-30 | $373 |
2018-03-31 | $354 |
2017-12-31 | $360 |
2017-09-30 | $292 |
2017-06-30 | $315 |
2017-03-31 | $319 |
2016-12-31 | $261 |
2016-09-30 | $304 |
2016-06-30 | $251 |
2016-03-31 | $248 |
2015-12-31 | $190 |
2015-09-30 | $317 |
2015-06-30 | $192 |
2015-03-31 | $192 |
2014-12-31 | $216 |
2014-09-30 | $249 |
2014-06-30 | $175 |
2014-03-31 | $364 |
2013-12-31 | $321 |
2013-09-30 | $219 |
2013-06-30 | $184 |
2013-03-31 | $200 |
2012-12-31 | $190 |
2012-09-30 | $180 |
2012-06-30 | $168 |
2012-03-31 | $206 |
2011-12-31 | $174 |
2011-09-30 | $166 |
2011-06-30 | $216 |
2011-03-31 | $232 |
2010-12-31 | $256 |
2010-09-30 | $231 |
2010-06-30 | $221 |
2010-03-31 | $200 |
2009-12-31 | $194 |
2009-09-30 | $173 |
2009-06-30 | $147 |
2009-03-31 | $97 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $25.527B | $8.120B |
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $124.048B | 15.56 |
Cencora (COR) | United States | $47.467B | 18.94 |
DiDi Global (DIDIY) | China | $23.901B | 0.00 |
Avantor (AVTR) | United States | $17.269B | 23.79 |
Viatris (VTRS) | United States | $13.856B | 3.96 |
CochLear (CHEOY) | $13.551B | 0.00 | |
Revvity (RVTY) | United States | $12.684B | 22.08 |
Charles River Laboratories (CRL) | United States | $12.333B | 22.48 |
Medpace Holdings (MEDP) | United States | $12.318B | 40.53 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.750B | 0.00 |
Natera (NTRA) | United States | $11.049B | 0.00 |
Solventum (SOLV) | United States | $10.961B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
HealthEquity (HQY) | United States | $6.795B | 50.77 |
Bausch + Lomb (BLCO) | Canada | $5.236B | 20.14 |
Organon (OGN) | United States | $4.783B | 4.63 |
Doximity (DOCS) | United States | $4.461B | 33.21 |
PACS (PACS) | United States | $3.596B | 0.00 |
Surgery Partners (SGRY) | United States | $3.228B | 30.00 |
Sotera Health (SHC) | United States | $3.190B | 15.65 |
Progyny (PGNY) | United States | $3.133B | 52.58 |
Life Times (LTH) | United States | $2.882B | 31.85 |
GoodRx Holdings (GDRX) | United States | $2.749B | 139.20 |
Premier (PINC) | United States | $2.531B | 9.26 |
Teladoc Health (TDOC) | United States | $2.325B | 0.00 |
Agilon Health (AGL) | United States | $2.191B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.167B | 7.01 |
BrightSpring Health Services (BTSG) | United States | $1.845B | 0.00 |
Agiliti (AGTI) | United States | $1.374B | 22.44 |
Establishment Labs Holdings (ESTA) | $1.344B | 0.00 | |
NovoCure (NVCR) | Jersey | $1.328B | 0.00 |
Alignment Healthcare (ALHC) | United States | $0.979B | 0.00 |
Pediatrix Medical (MD) | United States | $0.776B | 8.03 |
Embecta (EMBC) | United States | $0.627B | 4.14 |
Auna S.A (AUNA) | Luxembourg | $0.558B | 0.00 |
InnovAge Holding (INNV) | United States | $0.542B | 0.00 |
Enhabit (EHAB) | United States | $0.510B | 46.23 |
COMPASS Pathways (CMPS) | United Kingdom | $0.502B | 0.00 |
LifeMD (LFMD) | United States | $0.450B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.423B | 0.00 |
CareDx (CDNA) | United States | $0.413B | 0.00 |
Beauty Health (SKIN) | United States | $0.389B | 0.00 |
MultiPlan (MPLN) | United States | $0.375B | 0.00 |
DocGo (DCGO) | United States | $0.367B | 58.67 |
ModivCare (MODV) | United States | $0.353B | 4.68 |
Sera Prognostics (SERA) | United States | $0.326B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.308B | 0.00 |
Sharecare (SHCR) | United States | $0.277B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.265B | 0.00 |
Biodesix (BDSX) | United States | $0.145B | 0.00 |
So-Young (SY) | China | $0.121B | 40.67 |
Oncology Institute (TOI) | United States | $0.089B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.077B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
NeueHealth (NEUE) | United States | $0.053B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
Nutex Health (NUTX) | United States | $0.033B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.028B | 0.00 |
DermTech (DMTK) | United States | $0.021B | 0.00 |
OncoCyte (OCX) | United States | $0.020B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.014B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
OpGen (OPGN) | United States | $0.007B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.006B | 0.00 |
Assure Holdings (IONM) | United States | $0.005B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |